This site uses cookies to store information on your computer. Learn more x

DSM Venturing has sold a small part of its equity stake in Provexis plc.

Urmond, NL, 21 Apr 2010 11:00 CEST

DSM Venturing, the corporate venturing unit of Royal DSM N.V., announces that it has sold a small part of its equity stake in Provexis plc, an AIM listed company that develops and licenses ingredients for the functional food, medical food and dietary supplement market.

As a result of a prudent financial approach towards its investment portfolio, DSM Venturing opts to capitalize on part of the value created as a result of Provexis' shareprice development since DSM acquired its stake in August 2008. DSM remains a strategic stakeholder of the company, as illustrated by the recent announcement regarding the Letter of Intent for Provexis' Fruitflow technology with DSM Nutritional Products. After the sale announced today, DSM Venturing owns 197,769,230 shares, representing approximately 17.8% of the outstanding capital.